IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 361 - 380 of 1134 stories.
November 29, 2012
Cambrex (East Rutherford, NJ) says it has appointed Shlomo Yanai to its board of directors and will serve as its non-executive vice chairman.  Yanai was the president and CEO of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-appoints-former-Teva-CEO-as-board-vice-chairman_48016.html
November 28, 2012
BASF says it will acquire Pronova BioPharma (Lysaker, Norway), a pioneer in the field of research, development, and manufacturing of omega-3 fatty acids. BASF has reached an agreement...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-to-acquire-Pronova-BioPharma-for-$842-million_47876.html
November 28, 2012
Active pharmaceutical ingredients producer Hovione (Loures, Portugal) says it has established a collaboration with Solvias (Basel, Switzerland) focused on the development and good...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hovione-and-Solvias-collaborate-to-improve-drug-solubility_47970.html
November 27, 2012
BASF to acquire Pronova BioPharma for $842 million BASF says it will acquire Pronova BioPharma (Lysaker, Norway), a pioneer in the field of research, development, and manufacturing of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-27-November_47948.html
November 27, 2012
Lonza says that following recent negotiations, the company—together with the employees’ associations, operative commission, and unions Syna and Unia—have agreed on a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-and-unions-agree-on-cuts_47913.html
November 26, 2012
Aceto says its Rising Pharmaceuticals subsidiary has launched a generic version of clindamycin palmitate hydrochloride for oral solutions in pediatrics. The antibiotic used to treat...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aceto-launches-oral-pediatric-antibiotic_47918.html
November 23, 2012
The European Commission says that Switzerland has on 22 November been listed as the first non European Union (EU) country with active pharmaceutical ingredient (API) manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Switzerland-first-country-listed-under-new-rules-that-can-export-APIs-to-EU-without-written-confirmation_47909.html
November 22, 2012
The fine chemicals division of Johnson Matthey recorded a 2.8% fall in sales in the fiscal first half ended 30 September 2012, compared with the corresponding period of the previous...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Johnson-Mattheys-fine-chemicals-division-reports-rise-in-operating-profits_47902.html
November 20, 2012
Teva’s API business reports rise in sales Teva Pharmaceutical Industries (Petach Tikva, Israel), which has the largest active pharmaceutical ingredient (API) business in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-20-November_47853.html
November 20, 2012
The total revenue generated by the Asia/Pacific active pharmaceutical ingredient (API) market was $30.69 billion in 2011, and it is expected to grow at a compound annual growth rate of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Report-API-market-in-AsiaPacific-to-reach-$63-8-billion-by-2017_47847.html
November 14, 2012
Sigma-Aldrich Fine Chemicals (SAFC), the custom manufacturing and services business unit of Sigma-Aldrich, says it has added more than 25 new raw materials to its PharmaGrade products...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SAFC-expands-raw-materials-portfolio-for-biopharmaceutical-manufacturing_47684.html
November 13, 2012
EFCG says EU directive does not address API quality issues; calls for mandatory inspection of API manufacturing sites The European Fine Chemicals Group (EFCG; Brussels), an industry...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-13-November_47656.html
November 13, 2012
Lonza says it has started negotiations with the unions Syna and Unia to implement the recently announced job cuts. Lonza on 31 October announced it will cut 500 jobs globally...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-negotiates-with-unions-to-implement-job-cuts_47653.html
November 12, 2012
Orchid Chemicals & Pharmaceuticals (Chennai, India), a leading Indian pharmaceutical company, says it is exiting its 50-50 active pharmaceutical ingredient (API) manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Orchid-exits-API-jv-in-China_47632.html
November 8, 2012
Watson Pharmaceuticals (Parsippany, NJ) says it has completed the previously announced acquisition of generic pharmaceuticals company Actavis (Zug, Switzerland) for €4.25 billion...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Watson-completes-acquisition-of-Actavis-for-&euro4-25-billion_47446.html
November 6, 2012
Lonza to cut 500 jobs Lonza, in its business update announcement for the third quarter of 2012, says that it will make further efforts to improve the profitability of the company's...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-6-November_47471.html
November 6, 2012
Hikal (Mumbai), an outsourcing partner to companies in the pharma, biotech, agchem, and specialty chemical industries, has recorded a 81.9% fall in net profits for its fiscal...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hikal-reports-fall-in-profits_47470.html
November 6, 2012
Cambrex (East Rutherford, NJ) reported a 39% fall in net profits for the third quarter, ended 30 September 2012, compared with the year-ago period, to $1.68 million. Net sales...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-fall-in-profits_47467.html
November 5, 2012
The global high-potency active pharmaceutical ingredients (HPAPIs) market, which was worth $9.1 billion in 2011, is expected to reach $17.5 billion in 2018, growing at a compund annual...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Report-Global-high-potency-API-market-to-reach-$17-5-billion-in-2018_47447.html
Pages: « Previous  10 11 12 13 14 15 16 17 18 [19] 20 21 22 23 24 25 26 27 28 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa